This trial studies TAS-102 and oxaliplatin to see how well they work in treating patients with stage IV colon cancer.
1 Primary · 5 Secondary · Reporting Duration: Up to 2 years
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: Oxaliplatin · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:18 - 65 | 100.0% |
Saint Barnabas Medical Center | 100.0% |
Met criteria | 100.0% |